Who
Michael Amoroso
President and CEO
Company insider
Files Form 4 as: President and CEO, Precision BioSciences; Chief Executive Officer, Abeona Therapeutics.
In numbers
- Trades disclosed
- 83
- Buys
- 0
- Sells
- 18
- Bought
- $0
- Sold
- $1.0M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 2 Nov 2020
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —573,888 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —573,888 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $79K20,559 at $3.84 | filing |
| 18 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $79K20,559 at $3.84 | filing |
| 17 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —67,797 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —67,797 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —67,797 at $0.00 | filing |
| 17 Feb 2026filed 19 Feb 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —67,797 at $0.00 | filing |
| 26 Jan 2026filed 27 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —37,313 at $0.00 | filing |
| 26 Jan 2026filed 27 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —37,313 at $0.00 | filing |
| 22 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $145K34,799 at $4.17 | filing |
| 22 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Sold | $145K34,799 at $4.17 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —8,888 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —37,069 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesBiotechnology | SEC FORM 4 Code M | —69,421 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,888 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —37,069 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —69,421 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —8,888 at $0.00 | filing |
| 20 Jan 2026filed 22 Jan 2026 | DTIL Precision BioSciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —37,069 at $0.00 | filing |
News
Precision BioSciences, Inc. (NASDAQ:DTIL) Stock Has Consensus Price Target of $32.25DTIL · themarketsdaily.com · 17 Oct 2026
0 headlines in the last 90 days name Michael Amoroso; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.